Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/53640
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Type: Journal article
Title: Mannose-binding lectin status is associated with risk of major infection following myeloablative sibling allogeneic hematopoietic stem cell transplantation
Author: Mullighan, C.
Heatley, S.
Danner, S.
Dean, M.
Doherty, K.
Hahn, H.
Bradstock, K.
Minchinton, R.
Schwarer, A.
Szer, J.
Bardy, P.
Citation: Blood, 2008; 112(5):2120-2128
Publisher: Amer Soc Hematology
Issue Date: 2008
ISSN: 0006-4971
1528-0020
Statement of
Responsibility: 
Charles G. Mullighan, Susan L. Heatley, Silke Danner, Melinda M. Dean, Kathleen Doherty, Uwe Hahn, Kenneth F. Bradstock, Robyn Minchinton, Anthony P. Schwarer, Jeff Szer, and Peter G. Bardy
Abstract: Mannose-binding lectin (MBL) is a mediator of innate immunity that influences the risk of infection in a range of clinical settings. We previously reported associations between MBL2 genotype and infection in a retrospective study of myeloablative allogeneic hematopoietic stem cell transplantation (allo-HCT). However, other studies have been inconclusive, and the role of MBL in reduced-intensity conditioning (RIC) transplantation is unknown. Here we report a prospective study examining MBL2 genotype, MBL levels, and risk of major infection following HLA-matched sibling myeloablative (n = 83) and RIC (n = 59) HCT. Baseline MBL levels were higher in recipients than donors (P < .001), and recipient MBL levels increased during the peritransplantation period (P = .001), most notably in MBL2 wild-type individuals receiving myeloablative total body irradiation (mTBI). MBL2 coding mutations were associated with major infection in recipients receiving mTBI. The cumulative incidence of major infection in recipient harboring an MBL2 mutation receiving mTBI was 70.6%, compared with 31.1% of those without mutations not receiving mTBI (P = .01). MBL status was not associated with infection in RIC transplants. These results confirm the association of MBL status with risk of infection in myeloablative, TBI-conditioned transplantation. Studies examining the role of MBL replacement therapy to prevent infection in this setting should be considered.
Keywords: Humans; Infection; Graft vs Host Disease; Mannose-Binding Lectin; Hematopoietic Stem Cell Transplantation; Transplantation, Homologous; Risk Factors; Prospective Studies; Siblings; Genotype; Mutation, Missense; Polymorphism, Genetic; Adult; Middle Aged; Female; Male
RMID: 0020082479
DOI: 10.1182/blood-2007-07-100222
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.